• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

    29.84 -0.65 (-2.13%)
    Streaming Delayed Price Updated: 10:43 AM EST, Feb 13, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 685,507
    Open 30.72
    Bid (Size) 29.80 (100)
    Ask (Size) 29.88 (300)
    Prev. Close 30.49
    Today's Range 29.80 - 31.00
    52wk Range 18.92 - 43.15
    Shares Outstanding 99,581,693
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    VKTX Stock Has Nearly 300% Wall Street Upside — Is Viking’s Oral Obesity Pill The Next Novo Nordisk-Style Breakout? ↗
    The company ended 2025 with $706 million in cash, which it said is enough to fund ongoing Phase 3 trials and maintenance data readouts. 
    Via Stocktwits
    News headline image
    Viking Therapeutics Stock Soars: What's Driving The Momentum? ↗
    Viking Therapeutics (NASDAQ:VKTX) stock is soaring on Thursday, extending the momentum it picked up in Wednesday's after‑hours session following the company's fourth‑quarter earnings release. 
    Via Benzinga

    Performance

    YTD
    -15.8%
    -15.8%
    1 Month
    -2.8%
    -2.8%
    3 Month
    -23.5%
    -23.5%
    6 Month
    -25.8%
    -25.8%
    1 Year
    +1.8%
    +1.8%

    More News

    Read More
    Nasdaq, S&P 500 Futures Rise, Markets Await Jobless Claims: Why NVDA, META, NKTR, NVCR, AMAT, ASTS Are On Traders' Radar Today ↗
    Via Stocktwits
    Topics Stocks
    News headline image
    Viking (VKTX) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings Intellectual Property
    VKTX Shares Garner Retail Attention Ahead Of Q4 Earnings Report ↗
    Via Stocktwits
    Dow, S&P 500 Futures Climb As House Votes To Rescind Trump Tariffs: Why VKTX, NVCR, APP, CRM, QS Are Trending After-Hours ↗
    Via Stocktwits
    Topics Government Stocks
    News headline image
    VKTX Stock Rallies After Hours On Optimism Around Company’s Obesity Pipeline ↗
    Via Stocktwits
    News headline image
    Viking Therapeutics: The Under‑the‑Radar GLP‑1 Contender Growth Hunters Can't Ignore ↗
    Via The Motley Fool
    News headline image
    Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. ↗
    Via The Motley Fool
    News headline image
    Could Eli Lilly Turn Today's GLP‑1 Obesity Boom Into Multi‑Decade, Millionaire‑Maker Gains? ↗
    Via The Motley Fool
    News headline image
    3 Things Investors Need to Know About the Healthcare Sector in 2026 ↗
    Via The Motley Fool
    Topics Economy
    News headline image
    Eli Lilly Projects Record $80B-$83B Revenue for 2026 as Metabolic Franchise Decouples from Competition
    Via MarketMinute
    Topics Earnings Economy
    News headline image
    The Great GLP-1 Divergence: Eli Lilly Surges Toward Trillion-Dollar Dominance as Novo Nordisk Falters on U.S. Price Cuts
    Via MarketMinute
    Topics Earnings Economy
    News headline image
    The Smartest Growth Stock to Buy With $30 Right Now ↗
    Via The Motley Fool
    News headline image
    2 Biotech Stocks Set to Rebound in 2026 ↗
    Via The Motley Fool
    News headline image
    Eli Lilly or Viking Therapeutics: Which Stock Is More Likely to be a Millionaire-Maker? ↗
    Via The Motley Fool
    News headline image
    3 Growth Stocks to Invest $1,000 in Right Now ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    The Best Stocks to Invest $40 in to Start the New Year Off Right ↗
    Via The Motley Fool
    Topics Intellectual Property World Trade
    News headline image
    Viking Therapeutics (VKTX) 2026 Deep Dive: Challenging the Obesity Duopoly
    Via Finterra
    Topics Intellectual Property
    News headline image
    Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026 ↗
    Via The Motley Fool
    News headline image
    The Trillion-Dollar Heavyweight: Eli Lilly Surge Signals Unrivaled Dominance in the GLP-1 Era
    Via MarketMinute
    Topics Economy
    News headline image
    2 Bargain Stocks You Can Buy for Less Than $100 Right Now ↗
    Via The Motley Fool
    News headline image
    1 Stock That Could Soar by 175%, According to Wall Street ↗
    Via The Motley Fool
    News headline image
    What Happened to Viking Therapeutics in 2025, And Is it a Buy for 2026? ↗
    Via The Motley Fool
    News headline image
    3 Biotech Stocks That Look Like “Sure-Fire” Winners in 2026 ↗
    Via MarketBeat

    Frequently Asked Questions

    Is Viking Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Viking Therapeutics, Inc. - Common Stock trade on?
    Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?
    The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market
    What is the current price of Viking Therapeutics, Inc. - Common Stock?
    The current price of Viking Therapeutics, Inc. - Common Stock is 29.84
    When was Viking Therapeutics, Inc. - Common Stock last traded?
    The last trade of Viking Therapeutics, Inc. - Common Stock was at 02/13/26 10:43 AM ET
    What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?
    The market capitalization of Viking Therapeutics, Inc. - Common Stock is 2.97B
    How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?
    Viking Therapeutics, Inc. - Common Stock has 3B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.